JPH10273423A - Cosmetic for hair - Google Patents
Cosmetic for hairInfo
- Publication number
- JPH10273423A JPH10273423A JP9455797A JP9455797A JPH10273423A JP H10273423 A JPH10273423 A JP H10273423A JP 9455797 A JP9455797 A JP 9455797A JP 9455797 A JP9455797 A JP 9455797A JP H10273423 A JPH10273423 A JP H10273423A
- Authority
- JP
- Japan
- Prior art keywords
- hair
- cosmetic
- effect
- acid
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 46
- 210000004209 hair Anatomy 0.000 title claims description 65
- 235000019410 glycyrrhizin Nutrition 0.000 claims abstract description 18
- ONLRKTIYOMZEJM-UHFFFAOYSA-N n-methylmethanamine oxide Chemical compound C[NH+](C)[O-] ONLRKTIYOMZEJM-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000000203 mixture Substances 0.000 claims description 17
- 150000002342 glycyrrhetinic acids Chemical class 0.000 claims description 10
- 230000000694 effects Effects 0.000 abstract description 53
- MPDGHEJMBKOTSU-YKLVYJNSSA-N Glycyrrhetinic acid Natural products C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 abstract description 23
- 208000001840 Dandruff Diseases 0.000 abstract description 20
- 210000004761 scalp Anatomy 0.000 abstract description 18
- 208000003251 Pruritus Diseases 0.000 abstract description 14
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 abstract description 12
- 229960003720 enoxolone Drugs 0.000 abstract description 12
- -1 glycyrrhetinic acid compound Chemical class 0.000 abstract description 11
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract description 9
- 230000003405 preventing effect Effects 0.000 abstract description 9
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 abstract description 8
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 abstract description 8
- 239000001685 glycyrrhizic acid Substances 0.000 abstract description 8
- 229960004949 glycyrrhizic acid Drugs 0.000 abstract description 8
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 abstract description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 6
- CCXAYLQLOLXXKE-DWJAGBRCSA-K trisodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxylato-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-t Chemical compound [Na+].[Na+].[Na+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C([O-])=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O CCXAYLQLOLXXKE-DWJAGBRCSA-K 0.000 abstract description 3
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 abstract description 2
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 abstract description 2
- 238000013329 compounding Methods 0.000 abstract description 2
- 229940097043 glucuronic acid Drugs 0.000 abstract description 2
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 abstract 2
- 241000202807 Glycyrrhiza Species 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 abstract 1
- 239000000284 extract Substances 0.000 description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 30
- 201000004384 Alopecia Diseases 0.000 description 15
- 230000003779 hair growth Effects 0.000 description 12
- 208000024963 hair loss Diseases 0.000 description 12
- 230000003676 hair loss Effects 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 9
- 239000003676 hair preparation Substances 0.000 description 8
- 230000007803 itching Effects 0.000 description 8
- 239000006210 lotion Substances 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 230000003658 preventing hair loss Effects 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 5
- 239000004359 castor oil Substances 0.000 description 5
- 235000019438 castor oil Nutrition 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 229940121363 anti-inflammatory agent Drugs 0.000 description 4
- 239000002260 anti-inflammatory agent Substances 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 210000003780 hair follicle Anatomy 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 230000003797 telogen phase Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- CAKDFKUXFMLCAR-UIOGXPPZSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4S,5S,6S)-2-[[(3S,4aR,6aR,6bS,8aS,11S,12aR,14aR,14bS)-11-methoxycarbonyl-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]-6-carboxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@]1(C)CC[C@](C[C@H]14)(C)C(=O)OC)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O CAKDFKUXFMLCAR-UIOGXPPZSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 244000226021 Anacardium occidentale Species 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 241000499950 Arthropodium cirratum Species 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241000544061 Cuculus canorus Species 0.000 description 1
- 208000003024 Diffuse alopecia Diseases 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 235000003956 Luffa Nutrition 0.000 description 1
- 244000050983 Luffa operculata Species 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 241000183666 Nepsera aquatica Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical class CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 206010068168 androgenetic alopecia Diseases 0.000 description 1
- 201000002996 androgenic alopecia Diseases 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229940107588 barberry extract Drugs 0.000 description 1
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 description 1
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 description 1
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229940007061 capsicum extract Drugs 0.000 description 1
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 1
- 235000020226 cashew nut Nutrition 0.000 description 1
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000001599 crocus sativus l. flower extract Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229940072117 fennel extract Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000020737 peppermint extract Nutrition 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940119485 safflower extract Drugs 0.000 description 1
- 229940076591 saffron extract Drugs 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 229940048730 senega Drugs 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 230000004037 social stress Effects 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000003813 thin hair Effects 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、頭皮頭髪用化粧料
(以下,頭髪用化粧料という)に関する技術分野に属す
る発明である。より詳細には、優れた効果を有し,かつ
安全性にも優れる頭髪用化粧料に関する技術分野に属
し、本発明頭髪用化粧料は、特に医薬品,医薬部外品又
は化粧品の分野において用いられる。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention belongs to the technical field of scalp hair cosmetics (hereinafter referred to as hair cosmetics). More specifically, it belongs to the technical field of hair cosmetics having excellent effects and excellent safety, and the hair cosmetics of the present invention are used particularly in the field of pharmaceuticals, quasi-drugs or cosmetics. .
【0002】[0002]
【従来の技術】頭髪用化粧料には、様々な種類があり、
様々な頭皮頭髪状態に対応した製品が存在している。例
えば、頭皮状態によっては頭皮におけるフケやカユミを
防止することにより、脱毛状態等の現状を改善し得る製
品が開発されている。頭皮における様々なトラブルは、
高齢化社会を迎えた今日では、社会的ストレスの増大も
伴って増加しつつあり、この頭皮におけるトラブルに対
応した毛髪化粧料の需要は急増している。一般に、頭部
の禿や脱毛,毛の細り,頭皮のカユミやフケ等の原因と
しては、毛根の皮脂腺等の器官における男性ホルモンの
活性化,過剰な皮脂分泌,過酸化脂質の生成,毛包への
血流量の低下及びストレス等が挙げられる。また、丈夫
で美しい毛髪を育てるうえで、十分な毛包への栄養補給
が出来ない場合、細毛ややせ毛の原因となる。毛包への
血流量の低下は、栄養不足や老廃物の排泄の機能の低下
を招く。2. Description of the Related Art There are various types of hair cosmetics.
There are products for various scalp hair conditions. For example, products that can improve the current state of hair loss and the like by preventing dandruff and kayumi on the scalp depending on the scalp condition have been developed. Various troubles on the scalp
In today's aging society, social stress is increasing, and the demand for hair cosmetics corresponding to the scalp trouble is increasing rapidly. In general, the causes of baldness and hair loss on the head, thinning of hair, scalp Kayumi and dandruff are caused by activation of androgens in organs such as sebaceous glands of hair root, excessive sebum secretion, generation of lipid peroxide, hair follicles Blood flow to the skin and stress. In addition, when sufficient hair follicles cannot be supplied with nutrients to grow durable and beautiful hair, fine hair and thin hair may be caused. Decreased blood flow to the hair follicles leads to nutritional deficiency and reduced excretion of waste products.
【0003】このような観点から、頭皮における角質層
のターンオーバーや過剰な皮脂分泌等を改善すること
は、少なくとも頭皮における血流機能の低下を改善する
ことと共に、頭皮及び頭髪のトラブルを解決する上で欠
かせないポイントとなる。従来の頭髪用化粧料は、一般
的にこれらの禿や脱毛の原因と考えられる要素を取り除
いたり、軽減する作用を持つ物質を配合したものであ
る。例えば、ビタミンB,ビタミンE等のビタミン類、
セリン,メチオニン等のアミノ酸類、センブリエキス,
アセチルコリン誘導体等の血管拡張剤、紫根エキス等の
抗炎症剤、エストラジオール等の女性ホルモン剤、セフ
ァランチン等の皮膚機能亢進剤等が配合され、禿や脱
毛、毛髪の細りの予防及び治療に用いられている。[0003] From such a point of view, improving the horny layer turnover and excessive sebum secretion in the scalp improves the blood flow function at least in the scalp and solves problems in the scalp and hair. It is an indispensable point on the top. Conventional hair cosmetics generally contain a substance having an action of removing or reducing factors considered to be the cause of baldness and hair loss. For example, vitamins such as vitamin B and vitamin E,
Amino acids such as serine and methionine, assembly extract,
Contains vasodilators such as acetylcholine derivatives, anti-inflammatory agents such as purple root extract, female hormones such as estradiol, skin function enhancers such as cepharanthin, etc. I have.
【0004】[0004]
【発明が解決しようとする課題】しかしながら、これら
の成分を少量のみ頭髪用化粧料中に配合しても十分な効
果を得ることは難しく、逆に多く配合すると使用部分及
びその周辺に不快な刺激感や発赤を伴う傾向が強まり、
自ずと配合量には限界があった。However, it is difficult to obtain a sufficient effect even if only a small amount of these components is incorporated into the cosmetic for hair. There is a tendency to have a feeling and redness,
Naturally, the amount was limited.
【0005】そこで本発明が解決すべき課題は、優れた
効果を有し、かつ安全性にも優れる頭髪用化粧料を提供
することである。The problem to be solved by the present invention is to provide a cosmetic for hair which has excellent effects and is also excellent in safety.
【0006】[0006]
【課題を解決するための手段】本発明者は、この課題の
解決に向けて鋭意検討を行った。その結果、特定の消炎
剤と,特定のアミンオキシドとを組み合わせて配合する
ことにより、優れた脱毛防止効果や発毛効果,頭皮のカ
ユミ,フケの防止効果を有し、かつ安全性にも優れる頭
髪用化粧料が提供されることを見出し、本発明を完成し
た。Means for Solving the Problems The present inventor has made intensive studies to solve this problem. As a result, by combining a specific anti-inflammatory agent and a specific amine oxide in combination, it has an excellent hair loss preventing effect, a hair growth effect, an effect of preventing scalp Kayumi and dandruff, and is also excellent in safety. The present inventors have found that a cosmetic for hair is provided and completed the present invention.
【0007】すなわち本発明は、グリチルレチン酸類及
び/又はグリチルリチン酸類並びに下記式(I)で表さ
れるジメチルアミンオキシドThat is, the present invention relates to glycyrrhetinic acids and / or glycyrrhizic acids and dimethylamine oxide represented by the following formula (I):
【化2】 を含んでなる頭髪用化粧料を提供する。Embedded image And a hair cosmetic composition comprising:
【0008】[0008]
【発明の実施の形態】以下、本発明の実施の形態につい
て説明する。本発明頭髪用化粧料は、グリチルレチン酸
類及び/又はグリチルリチン酸類並びに上記のジメチル
アミンオキシド(I)を組み合わせて配合することによ
り、所期の効果を発揮する頭髪用化粧料である。Embodiments of the present invention will be described below. The hair cosmetic composition of the present invention is a hair cosmetic composition that exhibits desired effects by being combined with glycyrrhetinic acids and / or glycyrrhizic acids and the above-mentioned dimethylamine oxide (I).
【0009】本発明頭髪用化粧料中に配合されるグリチ
ルレチン酸類及びグリチルリチン酸類について説明す
る。本発明においてグリチルレチン酸類とは、グリチル
レチン酸及びグリチルレチン酸誘導体のことを意味す
る。The glycyrrhetinic acids and glycyrrhizic acids to be incorporated in the cosmetic for hair of the present invention will be described. In the present invention, glycyrrhetinic acids mean glycyrrhetinic acid and glycyrrhetinic acid derivatives.
【0010】グリチルレチン酸は、甘草から抽出したグ
リチルリチン酸のアグリコンであり、β−アミリン系に
属するトリテルペノイド化合物で、消炎剤として知られ
ており、製造法も公知であり,かつ市販もされている。
またグリチルレチン酸誘導体としては、例えばグリチル
レチン酸グリセリン,グリチルレチン酸ステアリル,グ
リチルレチン酸ピリドキシン等を挙げることが可能であ
り、これらの製造法は公知であり,かつ全て市販されて
いる。Glycyrrhetinic acid is an aglycone of glycyrrhizic acid extracted from licorice, a triterpenoid compound belonging to the β-amyrin family, known as an anti-inflammatory agent, its production method is also known, and it is commercially available.
Examples of the glycyrrhetinic acid derivative include glyceryl glyceryl glyceryl acid, stearyl glycyrrhetinic acid, pyridoxine glycyrrhetinic acid and the like, and their production methods are known and all are commercially available.
【0011】本発明において、グリチルリチン酸類と
は、グリチルリチン酸及びグリチルリチン誘導体のこと
を意味する。グリチルリチン酸は、甘草から抽出され,
1モルのグリチルレチン酸と2モルのグルクロン酸から
なる配糖体で、消炎剤として知られており、製造法も公
知であり,かつ市販もされている。In the present invention, glycyrrhizic acids mean glycyrrhizic acid and glycyrrhizin derivatives. Glycyrrhizic acid is extracted from licorice,
A glycoside consisting of 1 mol of glycyrrhetinic acid and 2 mol of glucuronic acid, which is known as an anti-inflammatory agent, has a known production method, and is commercially available.
【0012】またグリチルリチン酸誘導体としては、例
えばグリチルリチン酸三ナトリウム,グリチルリチン酸
三ナトリウム,グリチルリチン酸ジカリウム,グリチル
リチン酸メチル,グリチルリチン酸モノアンモニウム等
を挙げることが可能であり、これらの製造法は公知であ
り,かつ全て市販されている。これらのグリチルレチン
酸類とグリチルリチン酸類のうち、いずれか1種類を単
独で本発明頭髪用化粧料に配合することも可能である
が、2種以上を組み合わせて配合することも可能であ
る。Examples of the glycyrrhizic acid derivative include, for example, trisodium glycyrrhizinate, trisodium glycyrrhizinate, dipotassium glycyrrhizinate, methyl glycyrrhizinate, and monoammonium glycyrrhizinate, and their production methods are known. , And all are commercially available. Any one of these glycyrrhetinic acids and glycyrrhizic acids can be used alone in the cosmetic for hair of the present invention, but they can also be used in combination of two or more.
【0013】本発明頭髪用化粧料における上記のグリチ
ルレチン酸類及び/又はグリチルリチン酸類の配合量
は、頭髪用化粧料全体に対して0.001重量%以上,
5.0重量%以下であり、同0.01重量%以上,2.
0重量%以下が好ましい。The amount of the glycyrrhetinic acid and / or glycyrrhizic acid in the hair cosmetic of the present invention is 0.001% by weight or more based on the whole hair cosmetic.
5.0% by weight or less; 0.01% by weight or more;
It is preferably 0% by weight or less.
【0014】この配合量が頭髪用化粧料全体に対して
0.001重量%未満では十分な消炎効果等が発揮され
ず好ましくなく、同5.0重量%を超えて配合すると製
剤上不都合が生じる傾向が強まり、さらに皮膚刺激等が
伴う等,安全性の側面から問題が生じるおそれがある。If the amount is less than 0.001% by weight based on the total weight of the cosmetic for hair, a sufficient anti-inflammatory effect cannot be exerted, so that it is not preferable. If the amount exceeds 5.0% by weight, inconvenience is caused in the preparation. There is a possibility that a problem may arise from the aspect of safety, such as an increase in the tendency and further skin irritation.
【0015】上記のグリチルレチン酸類及び/又はグリ
チルリチン酸類と共に本発明毛髪化粧料中に配合され
る、上記ジメチルアミンオキシド(I)は通常公知のア
ミンオキシドの製造方法に従って製造することができ
る。その一例を示せば、概ね以下の工程に従って製造す
ることができる。The above-mentioned dimethylamine oxide (I) to be mixed with the above-mentioned glycyrrhetinic acids and / or glycyrrhizic acids in the hair cosmetic composition of the present invention can be produced according to a generally known method for producing an amine oxide. If an example is shown, it can be manufactured generally according to the following steps.
【0016】[0016]
【化3】 通常、このように製造したジメチルアミンオキシド
(I)は、再結晶法等の通常公知の精製法による精製工
程を経て本発明頭髪用化粧料中に配合する。Embedded image Usually, the dimethylamine oxide (I) thus produced is incorporated into the cosmetic for hair of the present invention through a purification step by a generally known purification method such as a recrystallization method.
【0017】本発明頭髪用化粧料中におけるこのジメチ
ルアミンオキシド(I)の配合量は、頭髪用化粧料全体
に対して0.0001重量%以上,20.0重量%以下
であり、同0.05重量%以上,5.0重量%以下が好
ましい。The amount of the dimethylamine oxide (I) in the cosmetic for hair of the present invention is 0.0001% by weight or more and 20.0% by weight or less based on the total amount of the cosmetic for hair. It is preferably from 05% by weight to 5.0% by weight.
【0018】この配合量が頭髪用化粧料全体に対して
0.0001重量%未満では、十分な消炎効果を発揮す
ることができず好ましくなく、同20.0重量%を超え
て配合すると、製剤上不都合を生ずる傾向が強くなり,
また皮膚刺激性が生ずる等の点から好ましくない。If the amount is less than 0.0001% by weight based on the total weight of the cosmetic for hair, a sufficient anti-inflammatory effect cannot be exerted, which is not preferable. The tendency to cause inconvenience becomes stronger,
Further, it is not preferable from the point that skin irritation occurs.
【0019】このようにして、上記消炎成分と上記ジメ
チルアミンオキシド(I)とを組み合わせて配合するこ
とにより、優れた脱毛防止効果や発毛効果,頭皮のカユ
ミ,フケの防止効果を有し、かつ安全性にも優れる本発
明頭髪用化粧料が提供される。Thus, by combining the anti-inflammatory component with the dimethylamine oxide (I) in combination, it has an excellent hair loss preventing effect and hair growth effect, and a scalp Kayumi and dandruff preventing effect. The present invention also provides a hair cosmetic composition which is excellent in safety.
【0020】なお、本発明頭髪用化粧料中には、通常頭
髪用化粧料中に配合される薬効成分を、その薬効成分が
有する一般的な効果を発揮させる目的のために、本発明
の所期の効果を損なわない限りにおいて配合することも
可能である。In the hair cosmetic composition of the present invention, the medicinal component usually incorporated in the hair cosmetic composition is used in order to exert the general effect of the medicinal component. It is also possible to mix as long as the effect of the period is not impaired.
【0021】例えば、セリン,メチオニン,アルギニン
等のアミノ酸類;ビタミンB6 ,ビオチン等のビタミン
類;パントテン酸若しくはその誘導体;エスラジオール
等の女性ホルモン等を本発明頭髪用化粧料中に配合する
こともできる。For example, amino acids such as serine, methionine and arginine; vitamins such as vitamin B 6 and biotin; pantothenic acid or derivatives thereof; and female hormones such as esladiol are incorporated into the cosmetic for hair of the present invention. Can also.
【0022】また、通常頭髪用化粧料中に配合される植
物抽出物、例えばアルテア抽出物,ヨクイニン抽出物,
ペパーミント抽出物,ヨウテイ抽出物,トウガラシ抽出
物,アロエ抽出物,クコ抽出物,ヨモギ抽出物,イネ抽
出物,マンケイシ抽出物,マンネンロウ抽出物,コッサ
イホ抽出物,エニシダ抽出物,リンドウ抽出物,タンジ
ン抽出物,ヘチマ抽出物,キキョウ抽出物,マツ抽出
物,クジン抽出物,トウキ抽出物,ベニバナ抽出物,メ
ギ抽出物,ビンロウジ抽出物,ユーカリ抽出物,カゴソ
ウ抽出物,モクソウ抽出物,ゴシツ抽出物,サイコ抽出
物,チャ抽出物,カンゾウ抽出物,ホップ抽出物,キク
抽出物,セネガ抽出物,ゴマ抽出物,センキュウ抽出
物,カシュウ抽出物,カッコン抽出物,マイカイカ抽出
物,サフラン抽出物,ローズマリー抽出物,ジオウ抽出
物,ゼニアオイ抽出物等を本発明頭髪用化粧料中に配合
することができる。Also, plant extracts, such as Altea extract, yoquinin extract, which are usually incorporated in hair cosmetics,
Peppermint extract, ginkgo biloba extract, capsicum extract, aloe extract, wolfberry extract, mugwort extract, rice extract, mankeishii extract, mannenwa extract, kossaiho extract, enishida extract, gentian extract, tangsin extract , Luffa extract, fennel extract, pine extract, kudin extract, touki extract, safflower extract, barberry extract, areca extract, eucalyptus extract, kagosou extract, mokusou extract, gossip extract, Psycho extract, tea extract, licorice extract, hop extract, chrysanthemum extract, senega extract, sesame extract, senkyu extract, cashew extract, cuckoo extract, Maikaika extract, saffron extract, rosemary An extract, a dirt extract, a mallow extract, and the like can be incorporated into the cosmetic for hair of the present invention.
【0023】また、亜鉛若しくはその誘導体;乳酸若し
くはそのアルキルエステル等;クエン酸等の有機酸類;
トラネキサム酸等のプロテアーゼ阻害剤;オリーブ油,
スクワラン,流動パラフィン,イソプロピルミリステー
ト,高級脂肪酸,高級アルコール等の油分;グリセリ
ン,プロピレングリコール等の多価アルコール;その他
界面活性剤,保湿剤,増粘剤,香料,酸化防止剤,紫外
線吸収剤,抗菌剤,清涼剤,色素,エタノール,水等を
本発明の所期の効果を損なわない範囲で適宜配合するこ
とができる。Zinc or a derivative thereof; lactic acid or an alkyl ester thereof; organic acids such as citric acid;
Protease inhibitors such as tranexamic acid; olive oil,
Oils such as squalane, liquid paraffin, isopropyl myristate, higher fatty acids and higher alcohols; polyhydric alcohols such as glycerin and propylene glycol; other surfactants, humectants, thickeners, fragrances, antioxidants, ultraviolet absorbers, Antibacterial agents, cooling agents, pigments, ethanol, water and the like can be appropriately compounded within a range that does not impair the intended effects of the present invention.
【0024】本発明頭髪用化粧料の形態は、液状,乳
液,軟膏等外皮に適用可能な性状のものであれば問われ
るものではなく、必要に応じて適宜基剤成分等を配合し
て所望の形態の本発明頭髪用化粧料を調製することがで
きる。また、本発明頭髪用化粧料は、医薬品,医薬部外
品又は化粧料等の多様な分野において適用可能である。The form of the cosmetic for hair of the present invention is not particularly limited as long as it can be applied to the outer skin such as liquid, emulsion, ointment and the like. Of the present invention can be prepared. Further, the cosmetic for hair of the present invention can be applied in various fields such as pharmaceuticals, quasi-drugs, and cosmetics.
【0025】本発明頭髪用化粧料は、例えば脱毛やフ
ケ,かゆみ等の治療や予防に用いることが可能であり、
例えば男性性脱毛症の治療や予防、女性に多いびまん性
脱毛症の治療や予防、円形脱毛症の治療等に広く用いる
ことができる。なお、ここに示した目的は例示であり、
これらの目的に本発明頭髪用化粧料の適用可能な疾患が
限定されるものではない。The hair cosmetic of the present invention can be used for treating or preventing hair loss, dandruff, itch and the like, for example.
For example, it can be widely used for treatment and prevention of androgenetic alopecia, treatment and prevention of diffuse alopecia common to women, treatment of alopecia areata and the like. In addition, the purpose shown here is an example,
The diseases applicable to the cosmetic for hair of the present invention are not limited to these objects.
【0026】本発明頭髪用化粧料は、概ね皮膚に直接塗
布又は散布する等の経皮投与により投与される(なお、
本発明頭髪用化粧料においては,上記必須成分の組み合
わせ配合により、成分の経皮吸収が促進される)。そし
て、本発明頭髪用化粧料の投与量は、年齢,脱毛の程度
等の個人差やその製剤形態に応じて適宜決定されるべき
ものであるが、一般の大人に対する投与量は、体重1Kg
当り0.001〜100mg/日、好ましくは0.1〜1
0mg/日であり、これを1日2〜4回に分けて投与する
ことができる。The hair cosmetic composition of the present invention is generally administered by transdermal administration such as directly applying or spraying on the skin.
In the hair cosmetic of the present invention, the percutaneous absorption of the components is promoted by the combination of the above essential components). The dosage of the cosmetic for hair of the present invention should be appropriately determined according to individual differences such as age and the degree of hair loss and the form of the preparation, but the dosage for general adults is 1 kg body weight.
0.001-100 mg / day, preferably 0.1-1
0 mg / day, which can be administered in 2 to 4 times a day.
【0027】[0027]
【実施例】以下、実施例等により本発明をより具体的に
説明するが、これらの実施例等により本発明の技術的範
囲が限定されるべきものではない。まず、各実施例等の
開示に先立ち、これらの実施例等の養毛効果等を検討す
るための試験について説明する。EXAMPLES Hereinafter, the present invention will be described more specifically with reference to Examples and the like, but the technical scope of the present invention should not be limited by these Examples and the like. First, prior to disclosure of each embodiment, a test for examining the hair growth effect and the like of each embodiment will be described.
【0028】1.養毛効果試験 本発明頭髪用化粧料の養毛効果を検討するために、トリ
コグラム試験を行った。被験者は、男性で比較例は各群
それぞれ5名及び実施例各群それぞれ4名とした。試験
塗布期間は4ヵ月間とし、この試料を1日2回、1回に
つき2〜4mlを頭皮に塗布した。塗布直前及び塗布4ヵ
月後に、それぞれ被験者1名につき頭頂部から毛髪を無
作為に50本抜去し、抜去毛の毛根を顕微鏡下で観察
し、毛根の状態から毛根休止期率(%)を計算した。試
料塗布前後における休止期率の増減の割合を以下の基準
で判定した。1. Hair- growth effect test In order to examine the hair-growth effect of the cosmetic for hair of the present invention, a tricogram test was performed. The subjects were male, and the comparative example was 5 in each group and 4 in each of the examples. The test application period was 4 months, and 2 to 4 ml of the sample was applied to the scalp twice a day. Immediately before application and 4 months after application, 50 hairs were randomly extracted from the crown of each subject, and the roots of the extracted hairs were observed under a microscope, and the root rest period rate (%) was calculated from the state of the roots. did. The rate of increase or decrease in the telogen rate before and after the sample application was determined based on the following criteria.
【0029】<判定基準> 顕著な効果(+):毛根休止期率が30%以上減少 弱い効果(±):毛根休止期率が10%以上,30%未
満の減少 効果なし(−):毛根休止期率が10%未満の減少<Judgment criteria> Remarkable effect (+): Hair root telogen rate decreased by 30% or more Weak effect (±): Hair root telogen rate reduced by 10% or more and less than 30% No effect (-): Hair root Pause rate reduced by less than 10%
【0030】2.脱毛防止効果試験 試料使用前後の洗髪脱毛本数の変化で脱毛防止効果を判
定した。被験者は男性で、男性で比較例は各群それぞれ
8名及び実施例各群それぞれ4名とした。試験期間は6
ヵ月間とし、前半2ヵ月間は試料を塗布しない期間,後
半4ヵ月は試料を塗布する期間とした。試料を塗布する
期間には、試料を1日2回、1回につき2〜4mlの試料
を頭皮に塗布した。試験期間中には、1日おきに洗髪し
て抜毛を回収し、1週間分をまとめてその毛の本数を数
えた。2. Hair loss prevention effect test The hair loss prevention effect was determined by the change in the number of hair washes before and after use of the sample. The subjects were males, and the males were 8 in each comparative example and 4 in each example. Test period is 6
The first two months were the period during which no sample was applied, and the last four months were the period during which the sample was applied. During the sample application period, the sample was applied to the scalp twice to four times a day at a time. During the test period, the hair was washed every other day to collect the extracted hairs, and the number of hairs was counted for one week.
【0031】各期間の抜毛本数の表示は、試料を塗布し
ない2カ月間,計8回の抜毛本数のデータと、試料を塗
布する期間の後半2ヵ月間,計8回の抜毛本数のデータ
をそれぞれの期間ごとにまとめ、平均値±標準偏差の形
で1回当りの抜毛本数として表示した。効果の判定は、
それぞれの期間の平均値の差から次のように判定した。The display of the number of hair removals during each period is based on the data of the number of hair removals eight times in total during the two months when the sample is not applied, and the data of the number of hair removals eight times in the latter two months of the application of the sample. The results were summarized for each period and displayed as the number of hair removals per time in the form of average value ± standard deviation. Judgment of the effect
Judgment was made as follows from the difference between the average values in each period.
【0032】<判定基準> ++:抜毛本数が70本以上減っており,著しい効果を
認めた +:抜毛本数が40本以上減っており,かなりの効果を
認めた ±:抜毛本数が10本以上減っており,やや効果が認め
られた −:抜毛本数の減少が10本未満であり,無効であった 脱毛防止効果の評価としては、+以上の被験者が50%
を超えた場合を有効とし、その他は無効とした。<Judgment Criteria> ++: The number of removed hairs was reduced by 70 or more, and a remarkable effect was recognized. +: The number of removed hairs was reduced by 40 or more, and a considerable effect was recognized. ±: The number of removed hairs was 10 or more. The number of hair loss was less than 10 and less than 50 hair removals were ineffective. The evaluation of the hair loss prevention effect was as follows: 50% or more subjects
Is valid when the value exceeds the limit, and invalid for the others.
【0033】3.ふけ,かゆみ防止効果試験 ふけ防止効果については、試料使用前後のふけ中の蛋白
質量の変化、かゆみの程度によって比較した。被験者は
実施例及び比較例で各群4名とした。試料塗布期間は3
ヶ月間とし、この間薬剤無添加の同一シャンプーで1日
1回洗髪し、試験試料を1日2回,1回につき2〜4ml
を頭皮に塗布した。3. Dandruff and itching prevention effect test The antidandruff effect was compared according to the change in the amount of protein in dandruff before and after use of the sample and the degree of itch. The subjects were four persons in each group in Examples and Comparative Examples. Sample application period is 3
The hair was washed once a day with the same shampoo containing no drug, and the test sample was washed twice a day, 2 to 4 ml each time.
Was applied to the scalp.
【0034】塗布直前及び3ヶ月塗布終了時に、被験者
より洗髪前に吸引装置によって頭部のふけを採取し、ふ
け中の蛋白質量を測定した。試料塗布前後における平均
ふけ量の増減によって、各試料のふけ防止効果を比較し
た。また、試験終了後に、各被験者の頭皮のかゆみにつ
いて調査し、かゆみの程度を以下のスコアで表した。Immediately before the application and at the end of the application for 3 months, the head dandruff was collected from the test subject with a suction device before washing the hair, and the amount of protein in the dandruff was measured. The anti-dandruff effect of each sample was compared by increasing and decreasing the average amount of dandruff before and after sample application. After the test, each subject was examined for scalp itch, and the degree of itch was expressed by the following score.
【0035】ふけ防止効果 +:顕著な効果 ±:弱い効果 −:効果なし Anti-dandruff effect +: remarkable effect ±: weak effect-: no effect
【0036】かゆみのスコア 3:強いかゆみがある 2:かゆみがある 1:ややかゆみがある 0:かゆみがない Itching score 3: Strong itching 2: Itching 1: Slight itching 0: No itching
【0037】〔実施例1〜6,比較例1〜3〕第1表
(実施例1〜6,比較例1〜3)に示した配合成分のロ
ーションを後述する製法に従って調製し、上記各試験を
行った。Examples 1 to 6 and Comparative Examples 1 to 3 Lotions of the components shown in Table 1 (Examples 1 to 6 and Comparative Examples 1 to 3) were prepared according to the production methods described below, and the above-mentioned tests were performed. Was done.
【0038】[0038]
【表1】 [Table 1]
【0039】<製法>95%エタノールに、各薬剤を各
配合量,プロピレングリコール,硬化ヒマシ油エチレン
オキシド(40モル)付加物,コハク酸及び香料を溶解
させた(エタノール相)。次いで精製水に色素を添加し
た後,溶解して、これを前記エタノール相に添加した
後,攪拌することにより、透明液状のローションを得
た。<Production Method> Each compounding agent, propylene glycol, hydrogenated castor oil ethylene oxide (40 mol) adduct, succinic acid and fragrance were dissolved in 95% ethanol (ethanol phase). Next, a dye was added to purified water, dissolved, and added to the ethanol phase, followed by stirring to obtain a clear liquid lotion.
【0040】上記各試験の結果を、第2表及び第3表
(養毛効果試験),第4表及び第5表(脱毛防止効果試
験)及び第6表(ふけ,かゆみ防止効果試験)に示し
た。The results of the above tests are shown in Tables 2 and 3 (hair growth effect test), Tables 4 and 5 (hair loss prevention effect test) and Table 6 (dandruff and itching prevention effect test). Indicated.
【表2】 [Table 2]
【0041】[0041]
【表3】 [Table 3]
【0042】[0042]
【表4】 [Table 4]
【0043】[0043]
【表5】 [Table 5]
【0044】[0044]
【表6】 [Table 6]
【0045】この結果より、上記のグリチルリチン酸類
やグリチルレチン酸類のいずれかとジメチルアミンオキ
シド(I)とを配合した実施例のローションには、養毛
効果,脱毛防止効果及びふけ,かゆみ防止効果が顕著に
認められたが、これらの消炎成分とジメチルアミンオキ
シド(I)のいずれか一方のみ配合した比較例の養毛ロ
ーションは、たとえこれらの成分を相当量配合しても、
これらの効果は上記実施例の結果と比べると著しく劣っ
ていた。From these results, it is apparent that the lotion of the embodiment in which any one of the above-mentioned glycyrrhizic acids and glycyrrhetinic acids is blended with dimethylamine oxide (I) has a remarkable hair-growth effect, a hair loss-preventing effect, and a dandruff and itching-preventing effect. Although it was recognized, the hair growth lotion of Comparative Example in which only one of these anti-inflammatory components and dimethylamine oxide (I) was blended, even if these components were blended in a considerable amount,
These effects were remarkably inferior to the results of the above examples.
【0046】すなわち、上記のグリチルリチン酸類やグ
リチルレチン酸類とジメチルアミンオキシド(I)とを
組み合わせて配合した本発明頭髪用化粧料においては、
相乗的な養毛効果,脱毛防止効果及びふけ,かゆみ防止
効果が顕著に認められることが明らかになった。このこ
とは、少量の有効成分であっても本発明頭髪用化粧料に
おいては所望する効果を得ることが可能であり、上記の
グリチルリチン酸類やグリチルレチン酸類を多量に配合
することによって惹起される、塗布部及びその周辺部の
不快な刺激感や発赤を防ぐことが可能になったことを示
すものである。That is, in the hair cosmetic composition of the present invention in which the above glycyrrhizic acids or glycyrrhetinic acids are combined with dimethylamine oxide (I),
It was found that the synergistic hair-raising effect, hair loss prevention effect, dandruff and itching prevention effect were remarkably observed. This means that the desired effect can be obtained in the hair cosmetic of the present invention even with a small amount of the active ingredient, and the coating effect caused by blending the glycyrrhizic acids and glycyrrhetinic acids in a large amount can be obtained. This indicates that it has become possible to prevent unpleasant irritation and redness of the part and its peripheral part.
【0047】以下、さらに他の本発明頭髪用化粧料の処
方例を示す。 〔実施例7〕 ローション (配合成分) 配合量(重量%) 95%エタノール 50.0 ジメチルアミンオキシド(I) 0.5 グリチルリチン酸モノアンモニウム 0.2 グリセリン 2.0 硬化ヒマシ油エチレンオキシド(40モル)付加物 0.8 リンゴ酸 適 量 香料及び色素 適 量 精製水 残 量Hereinafter, still another formulation example of the hair cosmetic composition of the present invention will be described. [Example 7] Lotion (Blending components) Blending amount (% by weight) 95% ethanol 50.0 Dimethylamine oxide (I) 0.5 Monoammonium glycyrrhizinate 0.2 Glycerin 2.0 Hardened castor oil ethylene oxide (40 mol) Additive 0.8 Malic acid qs Flavor and pigment qs Purified water balance
【0048】<製法>95%エタノールにジメチルアミ
ンオキシド(I),硬化ヒマシ油エチレンオキシド(4
0モル)付加物及び香料を溶解させた後(エタノール
相)、精製水に他の成分を添加して,これをエタノール
相に加えて攪拌溶解することによって、透明液状のロー
ションを得た。この本発明頭髪用化粧料に上記試験を行
ったところ、養毛効果,脱毛防止効果及びフケ・カユミ
防止効果が顕著に認められた。<Production method> Dimethylamine oxide (I) and hydrogenated castor oil ethylene oxide (4%) in 95% ethanol
After dissolving the adduct and the fragrance (0 mol) (ethanol phase), other components were added to purified water, and this was added to the ethanol phase and stirred and dissolved to obtain a clear liquid lotion. When the above-mentioned test was conducted on the cosmetic for hair of the present invention, a hair-growth effect, a hair loss-preventing effect, and a dandruff / kayumi-preventing effect were remarkably recognized.
【0049】 〔実施例8〕 ローション (配合成分) 配合量(重量%) 95%エタノール 90.0 ジメチルアミンオキシド(I) 3.0 β−グリチルレチン酸 1.0 1,3−ブチレングリコール 5.0 硬化ヒマシ油エチレンオキシド(50モル)付加物 1.0 ラウリル硫酸ナトリウム 0.5 乳酸 適 量 乳酸ナトリウム 適 量 香料及び色素 適 量 精製水 残 量Example 8 Lotion (Blending Components) Blending Amount (% by Weight) 95% Ethanol 90.0 Dimethylamine Oxide (I) 3.0 β-Glycyrrhetinic Acid 1.0 1,3-butylene glycol 5.0 Hardened castor oil ethylene oxide (50 mol) adduct 1.0 Sodium lauryl sulfate 0.5 Lactic acid qs Sodium lactate qs Perfume and pigment qs Purified water balance
【0050】<製法>95%エタノールに、硬化ヒマシ
油エチレンオキシド(50モル)付加物及び香料を溶解
させ、次いで精製水を添加後、他の成分を添加して攪拌
溶解し、透明液状のローションを得た。この本発明頭髪
用化粧料に上記試験を行ったところ、養毛効果,脱毛防
止効果及びフケ・カユミ防止効果が顕著に認められた。<Preparation method> A hydrogenated castor oil ethylene oxide (50 mol) adduct and a fragrance are dissolved in 95% ethanol, and then purified water is added. Then, other components are added and stirred to dissolve. Obtained. When the above-mentioned test was conducted on the cosmetic for hair of the present invention, a hair-growth effect, a hair loss-preventing effect, and a dandruff / kayumi-preventing effect were remarkably recognized.
【0051】 〔実施例9〕 乳液型頭髪用化粧料 (配合成分) 配合量(重量%) (1)セタノール 1.6 (2)ステアリン酸 1.0 (3)パルミチン酸 0.4 (4)液状ラノリン 1.0 (5)スクワラン 2.5 (6)モノステアリン酸グリセリル 1.5 (7)POEソルビタンモノステアレート 0.5 (8)ジメチルアミンオキシド(I) 1.0 (9)グリチルレチン酸ステアリル 0.1 (10)ジプロピレングリコール 5.0 (11)ポリエチレングリコール400 1.0 (12)トリエタノールアミン 1.0 (13)精製水 残 量[Example 9] Emulsion type cosmetic for hair (Blending components) Blending amount (% by weight) (1) Cetanol 1.6 (2) Stearic acid 1.0 (3) Palmitic acid 0.4 (4) Liquid lanolin 1.0 (5) Squalane 2.5 (6) Glyceryl monostearate 1.5 (7) POE sorbitan monostearate 0.5 (8) Dimethylamine oxide (I) 1.0 (9) Glycyrrhetinic acid Stearyl 0.1 (10) Dipropylene glycol 5.0 (11) Polyethylene glycol 400 1.0 (12) Triethanolamine 1.0 (13) Remaining purified water
【0052】<製法>(1)〜(9)の各成分を混合し
て、混合物1を調製し、別に(10)〜(13)の成分を混
合して混合物2を調製した。これらの混合物を別々に7
0℃に加熱溶解後、乳化機を用いて混合乳化した後、熱
交換冷却して、乳液型乳液型頭髪用化粧料を得た。この
本発明頭髪用化粧料に上記試験を行ったところ、養毛効
果,脱毛防止効果及びフケ・カユミ防止効果が顕著に認
められた。<Production Method> The components (1) to (9) were mixed to prepare a mixture 1, and the components (10) to (13) were separately mixed to prepare a mixture 2. These mixtures are separately
After heating and dissolving at 0 ° C, the mixture was mixed and emulsified using an emulsifier, and then heat-exchanged and cooled to obtain a latex-type latex hair cosmetic. When the above-mentioned test was conducted on the cosmetic for hair of the present invention, a hair-growth effect, a hair loss-preventing effect, and a dandruff / kayumi-preventing effect were remarkably recognized.
【0053】[0053]
【発明の効果】本発明により、優れた脱毛防止効果や発
毛効果,頭皮のカユミ,フケの防止効果を有し、かつ安
全性にも優れる頭髪用化粧料が提供される。Industrial Applicability According to the present invention, there is provided a hair cosmetic composition having an excellent hair loss preventing effect, a hair growth effect, an effect of preventing scalp kazumi and dandruff, and having excellent safety.
Claims (1)
チン酸類並びに下記式(I)で表されるジメチルアミン
オキシド 【化1】 を含んでなる頭髪用化粧料。1. Glycyrrhetinic acids and / or glycyrrhizic acids and dimethylamine oxide represented by the following formula (I): A hair cosmetic composition comprising:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9455797A JPH10273423A (en) | 1997-03-27 | 1997-03-27 | Cosmetic for hair |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9455797A JPH10273423A (en) | 1997-03-27 | 1997-03-27 | Cosmetic for hair |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH10273423A true JPH10273423A (en) | 1998-10-13 |
Family
ID=14113636
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9455797A Withdrawn JPH10273423A (en) | 1997-03-27 | 1997-03-27 | Cosmetic for hair |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH10273423A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6588964B1 (en) | 2000-10-10 | 2003-07-08 | The Procter & Gamble Company | Fluid applicator |
US7001594B1 (en) | 2000-10-10 | 2006-02-21 | The Procter & Gamble Company | Scalp cosmetic compositions and corresponding methods of application to provide scalp moisturization and skin active benefits |
JP2011184412A (en) * | 2010-03-11 | 2011-09-22 | Nippon Menaade Keshohin Kk | Emulsified composition, and skin care preparation for external use containing the same |
CN114392263A (en) * | 2021-12-20 | 2022-04-26 | 亿利耐雀生物科技有限公司 | Glycyrrhiza neoside hair loss prevention and hair growth promotion composition and preparation method thereof |
-
1997
- 1997-03-27 JP JP9455797A patent/JPH10273423A/en not_active Withdrawn
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6588964B1 (en) | 2000-10-10 | 2003-07-08 | The Procter & Gamble Company | Fluid applicator |
US7001594B1 (en) | 2000-10-10 | 2006-02-21 | The Procter & Gamble Company | Scalp cosmetic compositions and corresponding methods of application to provide scalp moisturization and skin active benefits |
JP2011184412A (en) * | 2010-03-11 | 2011-09-22 | Nippon Menaade Keshohin Kk | Emulsified composition, and skin care preparation for external use containing the same |
CN114392263A (en) * | 2021-12-20 | 2022-04-26 | 亿利耐雀生物科技有限公司 | Glycyrrhiza neoside hair loss prevention and hair growth promotion composition and preparation method thereof |
CN114392263B (en) * | 2021-12-20 | 2023-11-14 | 亿利耐雀生物科技有限公司 | Liquiritigenin hair-loss preventing and hair-growing composition and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH11269043A (en) | Cosmetic for scalp and hair | |
JPH11269042A (en) | Cosmetic for scalp and hair | |
WO1989002731A1 (en) | Hair tonic | |
JPH10273423A (en) | Cosmetic for hair | |
JP2001288046A (en) | Composition for scalp and hair | |
JPH10279437A (en) | Hair cosmetic | |
JP2001131031A (en) | Composition for scalp and hair | |
JPH11302133A (en) | Cosmetic for scalp and hair | |
JPH11255621A (en) | Cosmetic for scalp and hair | |
JPH10273424A (en) | Cosmetic for hair | |
JPH11302131A (en) | Cosmetic for scalp and hair | |
JP2000212057A (en) | Cosmetic composition | |
JPH11236319A (en) | Composition for scalp and hair | |
JPH11302128A (en) | Cosmetic for scalp and hair | |
JPH11263714A (en) | Cosmetic for scalp and hair of head | |
EP0679385B1 (en) | Hair revitalizing composition | |
JPH10273422A (en) | Cosmetic for hair | |
JPH0640858A (en) | Hair tonic | |
JPH11152211A (en) | Cosmetic for scalp and hair of head | |
JPH11322545A (en) | Cosmetic for scalp and hair | |
JPH11322546A (en) | Cosmetic for scalp and hair | |
JPH1017440A (en) | Hair growing and restoring agent | |
JP2000044436A (en) | Composition for scalp and hair treatment | |
JP2862623B2 (en) | Hair restoration | |
JPH07149614A (en) | Hair tonic agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20040601 |